While the myelofibrosis drug landscape has become more crowded since Syntara (then Pharmaxis) decided to focus on that ...

Brazil's health regulators have approved Telix Pharmaceuticals' nuclear imaging agent for prostate cancer, Illucix.

John Amos, Dr. Farhad Zangeneh, Medical Director of Endocrine, Diabetes and Osteoporosis Clinic, Dr. Dina Peralta-Reich, New York Weight Wellness Medicine Founder and Director, and Peter Maher, a ...

Sumatriptan and others are contraindicated in patients taking monoamine oxidase (MAO ... headaches), isometheptene (a sympathomimetic amine with vasoconstriction properties) and dichloralphenazone ...

It’s been two years since Aminé’s last album, Kaytraminé, which was a collaboration with Kaytranada. Today, the Portland rapper is sharing a preview of its followup with the new song ...

Aminé is officially in album mode. After clearing his Instagram earlier in the week to drop an influx of new album-related content, the rapper has returned with his first new single of 2025. Enti ...

August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new ...

August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.